Obesity associated with increased postmenopausal invasive breast cancer risk

the ONA take:

Obesity is associated with increased risk for invasive breast cancer in postmenopausal women, a new study published online ahead of print in JAMA Oncology has shown.

For the secondary analysis, researchers sought to investigate the associations of overweight and obesity with the risk of developing postmenopausal invasive breast cancer after a long follow-up in the Women's Health Initiative studies.

Researchers analyzed data from 67,142 postmenopausal women ages 50 to 79 years. Patients were followed for a median of 13 years. During that time, 3,388 patients were diagnosed with invasive breast cancers.

Results showed that women who were overweight and obese had an increased risk for developing invasive breast cancer compared with those of normal weight. Researchers found that women with a BMI of 35.0 or higher was strongly associated with risk of developing estrogen receptor-positive and progesterone receptor-negative breast cancers.

The findings suggest that more strategies should be developed to prevent obesity in postmenopausal women.

Obesity associated with increased postmenopausal invasive breast cancer risk
Obesity is associated with increased risk for invasive breast cancer in postmenopausal women.
More than two-thirds of US women are overweight or obese, placing them at increased risk for postmenopausal breast cancer.
READ FULL ARTICLE From oncology.jamanetwork.com
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs